Latest Rosiglitazone Stories
RESEARCH TRIANGLE PARK, N.C., Feb. 24 /PRNewswire-FirstCall/ -- Today, GlaxoSmithKline (NYSE: GSK) responded to the recently released Senate Committee on Finance's January 2010 "Staff Report on GlaxoSmithKline and the Diabetes Drug Avandia" (the "Staff Report").
A Henry Ford Hospital study finds women with type 2 diabetes who take a commonly prescribed class of medications to treat insulin resistance may be at a higher risk for developing bone fractures.
LOS ALTOS, Calif., Jan. 11 /PRNewswire/ -- InteKrin Therapeutics Inc. will present at the 28th Annual JP Morgan Global Healthcare Conference at 4:00 p.m. Pacific Time on Monday, January 11, 2010, to be held at the Westin St. Francis in San Francisco, California.
Research: Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: Retrospective cohort study using UK general practice research database.
NEW YORK, Nov.
Research published this week in the open access journal, PLoS Medicine, suggests that there is an association between thiazolidinediones â€“ a type of drug introduced in the 1990s to treat type 2 diabetes â€“ and bone fracture.
Insulin resistance, the hallmark of type 2 diabetes and a condition often associated with obesity, is paradoxically also an apparent contributor to muscle wasting and severe fat loss that accompanies some cancers, according to new research.
Canadian scientists say they have discovered rosiglitazone (Avandia) a type 2 diabetes drug, might be linked with increased risk of heart failure and death. The scientists from the University of Toronto and the Sunnybrook Health Sciences Center in Toronto, said the linkage was found among older patients, compared to a similar drug, pioglitazone (Actos). The scientists used prescription records to identify nearly 40,000 patients aged 66 years and older who started treatment with either...
Rosiglitazone, a drug used to treat type 2 diabetes, is associated with an increased risk of heart failure and death among older patients compared to a similar drug (pioglitazone), concludes a study published on bmj.com today.
- totally perplexed and mixed up.